• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秋水仙碱对心包疾病的影响:文献综述与当前证据

Effects of colchicine on pericardial diseases: a review of the literature and current evidence.

作者信息

Shah Syed Raza, Alweis Richard, Shah Syed Arbab, Arshad Mohammad Hussham, Manji Adil Al-Karim, Arfeen Arham Amir, Javed Maheen, Shujauddin Syed Muhammad, Irfan Rida, Shabbir Sakina, Shaikh Shehryar

机构信息

Department of Medicine, Dow University of Health Sciences (DUHS), Karachi, Pakistan;

Department of Internal Medicine, Reading Health System, West Reading, PA, USA.

出版信息

J Community Hosp Intern Med Perspect. 2016 Jul 6;6(3):31957. doi: 10.3402/jchimp.v6.31957. eCollection 2016.

DOI:10.3402/jchimp.v6.31957
PMID:27406462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4942520/
Abstract

Colchicine, extracted from the colchicum autumnale plant, used by the ancient Greeks more than 20 centuries ago, is one of the most ancient drugs still prescribed even today. The major mechanism of action is binding to microtubules thereby interfering with mitosis and subsequent modulation of polymorphonuclear leukocyte function. Colchicine has long been of interest in the treatment of cardiovascular disease; however, its efficacy and safety profile for specific conditions have been variably established in the literature. In the subset of pericardial diseases, colchicine has been shown to be effective in recurrent pericarditis and post-pericardiotomy syndrome (PPS). The future course of treatment and management will therefore highly depend on the results of the ongoing large randomized placebo-controlled clinical trial to evaluate the efficacy and safety of colchicine for the primary prevention of several postoperative complications and in the perioperative period. Also, given the positive preliminary outcomes of colchicine usage in pericardial effusions, the future therapeutical use of colchicine looks promising. Further study is needed to clarify its role in these disease states, as well as explore other its role in other cardiovascular conditions.

摘要

秋水仙碱是从秋水仙植物中提取的,早在20多个世纪前就被古希腊人使用,它是至今仍在使用的最古老的药物之一。其主要作用机制是与微管结合,从而干扰有丝分裂并随后调节多形核白细胞功能。秋水仙碱长期以来一直用于治疗心血管疾病;然而,其在特定病症中的疗效和安全性在文献中尚未完全明确。在心包疾病的亚组中,秋水仙碱已被证明对复发性心包炎和心包切开术后综合征(PPS)有效。因此,未来的治疗和管理过程将高度依赖于正在进行的大型随机安慰剂对照临床试验的结果,以评估秋水仙碱在预防多种术后并发症及围手术期的疗效和安全性。此外,鉴于秋水仙碱在心包积液中的初步积极结果,秋水仙碱未来的治疗用途看起来很有前景。需要进一步研究以阐明其在这些疾病状态中的作用,以及探索其在其他心血管疾病中的作用。

相似文献

1
Effects of colchicine on pericardial diseases: a review of the literature and current evidence.秋水仙碱对心包疾病的影响:文献综述与当前证据
J Community Hosp Intern Med Perspect. 2016 Jul 6;6(3):31957. doi: 10.3402/jchimp.v6.31957. eCollection 2016.
2
Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation.COlchicine 用于预防心包切开术后综合征和术后心房颤动(COPPS-2 试验)的原理和设计:一项关于预防性使用秋水仙碱预防心包切开术后综合征、术后积液和术后心房颤动的随机、安慰剂对照、多中心研究。
Am Heart J. 2013 Jul;166(1):13-9. doi: 10.1016/j.ahj.2013.03.025. Epub 2013 May 6.
3
[Prevention of the postpericardiotomy syndrome, postoperative effusions, and atrial fibrillation after cardiac surgery, efficacy and safety of colchicine: evidence from the COPPS trial and substudies].[心脏手术后心包切开术后综合征、术后积液及心房颤动的预防:秋水仙碱的疗效和安全性:来自COPPS试验及亚研究的证据]
G Ital Cardiol (Rome). 2012 Oct;13(10):665-72. doi: 10.1714/1145.12619.
4
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial.秋水仙碱预防心包切开术后综合征和术后心房颤动:COPPS-2 随机临床试验。
JAMA. 2014 Sep 10;312(10):1016-23. doi: 10.1001/jama.2014.11026.
5
Effectiveness of colchicine for the prevention of recurrent pericarditis and post-pericardiotomy syndrome: an updated meta-analysis of randomized clinical data.秋水仙碱预防复发性心包炎和心包切开术后综合征的有效性:随机临床数据的更新荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):117-25. doi: 10.1093/ehjcvp/pvv001. Epub 2015 Feb 19.
6
COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial.秋水仙碱预防心包切开术后综合征(COPPS):一项多中心、随机、双盲、安慰剂对照试验。
Eur Heart J. 2010 Nov;31(22):2749-54. doi: 10.1093/eurheartj/ehq319. Epub 2010 Aug 30.
7
Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome.秋水仙碱治疗心包炎及心包切开术后综合征价值的荟萃分析。
BMC Cardiovasc Disord. 2019 Sep 2;19(1):207. doi: 10.1186/s12872-019-1190-4.
8
Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine.秋水仙碱在心脏疾病中的应用:从基础生物学和临床获益到心血管医学中的药物相互作用。
Curr Cardiol Rep. 2018 Jun 14;20(8):62. doi: 10.1007/s11886-018-1008-5.
9
The Role of Colchicine in Pericardial Syndromes.秋水仙碱在心包综合征中的作用。
Curr Pharm Des. 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823.
10
Colchicine prevents early postoperative pericardial and pleural effusions.秋水仙碱可预防术后早期心包和胸腔积液。
Am Heart J. 2011 Sep;162(3):527-32.e1. doi: 10.1016/j.ahj.2011.05.017. Epub 2011 Jul 18.

引用本文的文献

1
[Colchicine, an old friend's perspectives for rheumatology in COVID-19: a scoping review].[秋水仙碱:老朋友对COVID-19中风湿病学的看法:一项范围综述]
Rev Colomb Reumatol. 2022 Jun;29:S35-S47. doi: 10.1016/j.rcreu.2021.02.002. Epub 2021 Mar 27.
2
Occurrence and predictors of pericardial effusion requiring invasive treatment following heart valve surgery.心脏瓣膜手术后需要侵入性治疗的心包积液的发生和预测因素。
Open Heart. 2022 Jan;9(1). doi: 10.1136/openhrt-2021-001880.
3
Is There a Role for Colchicine in Acute Coronary Syndromes? A Literature Review.秋水仙碱在急性冠状动脉综合征中是否有作用?文献综述。
Cureus. 2020 May 17;12(5):e8166. doi: 10.7759/cureus.8166.
4
Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?秋水仙碱作为一种古老的抗炎药物,对新冠病毒肺炎是否有效?
J Clin Pharmacol. 2020 Jul;60(7):828-829. doi: 10.1002/jcph.1645. Epub 2020 May 23.
5
Using left ventricular assist devices in advanced heart failure patients.在晚期心力衰竭患者中使用左心室辅助装置。
J Community Hosp Intern Med Perspect. 2018 Dec 11;8(6):357-359. doi: 10.1080/20009666.2018.1536240. eCollection 2018.
6
Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence.心房颤动-扑动的管理:基于当前证据的最新指南文件
J Community Hosp Intern Med Perspect. 2018 Oct 15;8(5):269-275. doi: 10.1080/20009666.2018.1514932. eCollection 2018.
7
Atrial fibrillation and heart failure- results of the CASTLE-AF trial.心房颤动与心力衰竭——CASTLE-AF试验结果
J Community Hosp Intern Med Perspect. 2018 Aug 23;8(4):208-210. doi: 10.1080/20009666.2018.1495979. eCollection 2018.
8
Right ventricular dysplasia: management and treatment in light of current evidence.右心室发育不良:基于当前证据的管理与治疗
J Community Hosp Intern Med Perspect. 2018 Jun 12;8(3):101-106. doi: 10.1080/20009666.2018.1472513. eCollection 2018.
9
Topical vasodilator response in skeletonized internal mammary artery: Is there really a difference?骨骼化乳内动脉的局部血管扩张剂反应:真的存在差异吗?
Avicenna J Med. 2017 Jan-Mar;7(1):23-27. doi: 10.4103/2231-0770.197510.

本文引用的文献

1
Recovery of myofilament function through reactivation of glycogen synthase kinase 3β (GSK-3β): mechanism for cardiac resynchronization therapy.通过糖原合酶激酶3β(GSK-3β)的再激活恢复肌丝功能:心脏再同步治疗的机制
J Interv Card Electrophysiol. 2014 Dec;41(3):193-4. doi: 10.1007/s10840-014-9939-2. Epub 2014 Sep 26.
2
Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial.秋水仙碱治疗多发性心包炎复发的疗效和安全性(CORP-2):一项多中心、双盲、安慰剂对照、随机试验。
Lancet. 2014 Jun 28;383(9936):2232-7. doi: 10.1016/S0140-6736(13)62709-9. Epub 2014 Mar 30.
3
A randomized trial of colchicine for acute pericarditis.秋水仙碱治疗急性心包炎的随机试验。
N Engl J Med. 2013 Oct 17;369(16):1522-8. doi: 10.1056/NEJMoa1208536. Epub 2013 Aug 31.
4
Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation.COlchicine 用于预防心包切开术后综合征和术后心房颤动(COPPS-2 试验)的原理和设计:一项关于预防性使用秋水仙碱预防心包切开术后综合征、术后积液和术后心房颤动的随机、安慰剂对照、多中心研究。
Am Heart J. 2013 Jul;166(1):13-9. doi: 10.1016/j.ahj.2013.03.025. Epub 2013 May 6.
5
Prevention of recurrent pericarditis with colchicine in 2012.2012 年秋水仙碱预防复发性心包炎。
Clin Cardiol. 2013 Mar;36(3):125-8. doi: 10.1002/clc.22098. Epub 2013 Feb 12.
6
Impact of colchicine on pericardial inflammatory syndromes--an analysis of randomized clinical trials.
Int J Cardiol. 2012 Nov 1;161(1):59-62. doi: 10.1016/j.ijcard.2012.06.040. Epub 2012 Jul 5.
7
Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.在急性和复发性心包炎中使用阿司匹林、非甾体抗炎药、皮质类固醇和秋水仙碱治疗。
Heart Fail Rev. 2013 May;18(3):355-60. doi: 10.1007/s10741-012-9328-9.
8
Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis.秋水仙碱预防心包炎的疗效和安全性。系统评价和荟萃分析。
Heart. 2012 Jul;98(14):1078-82. doi: 10.1136/heartjnl-2011-301306. Epub 2012 Mar 22.
9
Colchicine in acute pericarditis: a new standard?秋水仙碱用于急性心包炎:一种新标准?
Arch Cardiovasc Dis. 2011 Aug;104(8-9):425-7. doi: 10.1016/j.acvd.2011.06.002. Epub 2011 Aug 27.
10
Colchicine prevents early postoperative pericardial and pleural effusions.秋水仙碱可预防术后早期心包和胸腔积液。
Am Heart J. 2011 Sep;162(3):527-32.e1. doi: 10.1016/j.ahj.2011.05.017. Epub 2011 Jul 18.